UPI

Study: ACE inhibitors, ARBs don't increase risk for COVID-19

May 5 (UPI) --Certain high blood pressure medications have been linked with more serious illness from COVID-19, but they don't increase a person's risk for getting the disease, a new study published ...
Business Wire

ACE-Breast-02 Pivotal Phase 3 Study of Ambrx’s ARX788 for the Treatment of HER2 Positive Metastatic Breast Cancer Achieves Positive Results

SAN DIEGO--(BUSINESS WIRE)--Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM) announced today that it has been informed by its partner, NovoCodex Biopharmaceuticals, Inc. (NovoCodex), that an interim ...
TCTMD

Retracted Over Fraud Concerns, Surgisphere ACE/ARB Study Still Gets Cited

A high-profile study that purported to provide the first reassurances ACE inhibitors and ARBs could be safely used in the setting of COVID-19 continues to be cited long after it was retracted over ...
TCTMD

ACE-PROTAVI Data Solidify Protamine’s Role in Aortic Interventions

The routine use of protamine for heparin reversal during TAVI improves and hastens hemostasis, data from the randomized ACE-PROTAVI trial confirm. The results, published online this week in JAMA ...